Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis
- PMID: 12082545
- PMCID: PMC1531706
- DOI: 10.1038/sj.neo.7900251
Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis
Abstract
To identify a set of genes related to radiosensitivity of cervical squamous cell carcinomas and to establish a predictive method, we compared expression profiles of 9 radiosensitive and 10 radioresistant tumors obtained by biopsy before treatment, on a cDNA microarray consisting of 23,040 human genes. We identified 121 genes whose expression was significantly greater in radiosensitive cells than in radioresistant cells, and 50 genes that showed higher levels of expression in radioresistant cells than in radiosensitive cells. Some of these genes had already known to be associated with the radiation response, such as aldehyde dehydrogenase 1 (ALDH1) and X-ray repair cross-complementing 5 (XRCC5) (P<.05, Mann-Whitney test). The validity of the total of 171 genes as radiosensitivity related genes were certified by permutation test (P<.05). Furthermore, we selected 62 genes on the basis of a clustering analysis, and confirmed the validity of these genes with cross-validation test. The cross-validation test also indicates the possibility of making prediction of radiosensitivity for discriminating radiation-sensitive from radiation resistant biopsy samples by predicting score (PS) values calculated from expression values of 62 genes in 19 samples, because the prediction successfully and unequivocally discriminated the radiosensitive phenotype from the radioresistant phenotype in our test panel of 19 cervical carcinomas. The extensive list of genes identified in these experiments provides a large body of potentially valuable information for studying the mechanism(s) of radiosensitivity, and selected 62 genes opens the possibility of providing appropriate and effective radiotherapy to cancer patients.
Figures
Similar articles
-
Gene expression pattern associated with radiotherapy sensitivity in cervical cancer.Cancer J. 2006 May-Jun;12(3):189-93. doi: 10.1097/00130404-200605000-00006. Cancer J. 2006. PMID: 16803676
-
Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression.Cytogenet Cell Genet. 2000;91(1-4):39-43. doi: 10.1159/000056815. Cytogenet Cell Genet. 2000. PMID: 11173827
-
[Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].Rev Invest Clin. 2005 May-Jun;57(3):434-41. Rev Invest Clin. 2005. PMID: 16187704 Spanish.
-
Identification of candidate radioresistant genes in human squamous cell carcinoma cells through gene expression analysis using DNA microarrays.Oncol Rep. 2005 Nov;14(5):1293-8. Oncol Rep. 2005. PMID: 16211299
-
The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies.Clin Lab Haematol. 2003 Aug;25(4):209-20. doi: 10.1046/j.1365-2257.2003.00532.x. Clin Lab Haematol. 2003. PMID: 12890159 Review.
Cited by
-
Review of possible mechanisms of radiotherapy resistance in cervical cancer.Front Oncol. 2023 Aug 22;13:1164985. doi: 10.3389/fonc.2023.1164985. eCollection 2023. Front Oncol. 2023. PMID: 37692844 Free PMC article. Review.
-
Recent progress of the tumor microenvironmental metabolism in cervical cancer radioresistance.Front Oncol. 2022 Oct 12;12:999643. doi: 10.3389/fonc.2022.999643. eCollection 2022. Front Oncol. 2022. PMID: 36313645 Free PMC article. Review.
-
Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics.Front Oncol. 2022 Jul 29;12:967386. doi: 10.3389/fonc.2022.967386. eCollection 2022. Front Oncol. 2022. PMID: 35965520 Free PMC article.
-
N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.Mil Med Res. 2022 Apr 14;9(1):19. doi: 10.1186/s40779-022-00378-z. Mil Med Res. 2022. PMID: 35418160 Free PMC article.
-
On the Evaluation of a Novel Hypoxic 3D Pancreatic Cancer Model as a Tool for Radiotherapy Treatment Screening.Cancers (Basel). 2021 Dec 2;13(23):6080. doi: 10.3390/cancers13236080. Cancers (Basel). 2021. PMID: 34885188 Free PMC article.
References
-
- Vutuc C, Haidinger G, Waldhoer T, Ahmad F, Breitenecker G. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Wien Klin Wochenschr. 1999;111:354–359. - PubMed
-
- Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears. Eur J Gynaecol Oncol. 1998;19:203–208. - PubMed
-
- Suzuki K, Watanabe M, Miyoshi J. Differences in effects of oncogenes on resistance of gamma rays, ultraviolet light, and heat shock. Radiat Res. 1992;129:157–162. - PubMed
-
- FitzGerald TJ, Henault S, Sakakeeny M, Santucci MA, Pierce JH, Anklesaria P, Kase K, Das I, Greenberger JS. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate. Radiat Res. 1990;122:44–52. - PubMed
-
- Riva C, Lavieille JP, Reyt E, Brambilla E, Lunardi J, Brambilla C. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Eur J Cancer Part B Oral Oncol. 1995;31B:384–391. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous